AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 11

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.31 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019954TB-500HJHJ-2501-A6454Janoshik2025-Q199.664.9590.1Buyer-sourced1MARGINAL
AX-2025-019863IGF-1 LR3HJHJ-2410-G5632Medutest2025-Q198.283.10—Buyer-sourced1MARGINAL
AX-2025-019724TB-500HomopeptideHOMO-2410-E3347Medutest2025-Q199.935.63—Buyer-sourced0PASS
AX-2025-019377GHRP-2HYBHYB-2501-R7240Janoshik2025-Q199.935.27105.6Laboratory-retained0PASS
AX-2025-019005HexarelinASYASY-{CAT}-1786Janoshik2025-Q199.914.76103.5Buyer-sourced0PASS
AX-2025-019003HexarelinASYASY-{CAT}-1786Janoshik2025-Q199.934.8989.7Buyer-sourced1MARGINAL
AX-2025-018675TirzepatideQSCQSC-2410-R5814PeptideMeter2025-Q199.305.4894.0Buyer-sourced0PASS
AX-2025-018581SemaglutideQYBQYB-2410-V4909Janoshik2025-Q199.853.40—Buyer-sourced0PASS
AX-2025-018506SemaglutideWWBWWB-2501-K3141Nordanalyt2025-Q198.434.13—Buyer-sourced1MARGINAL
AX-2025-018478TirzepatideWWBWWB-2502-U2990Janoshik2025-Q198.713.8789.3Buyer-sourced2MARGINAL
AX-2025-018439SemaglutideWWBWWB-2501-Y2776Janoshik2025-Q199.323.72102.4Buyer-sourced0PASS
AX-2025-018427SemaglutideWWBWWB-2501-S2183Janoshik2025-Q198.833.64104.1Buyer-sourced0PASS
AX-2025-020016AOD-9604SWBSWB-2502-N7040Janoshik2025-Q199.365.4996.9Buyer-sourced0PASS
AX-2025-019758SemaglutideHomopeptideHOMO-2501-D4523Nordanalyt2025-Q199.435.2198.3Buyer-sourced0PASS
AX-2025-019658AfamelanotideTFCTFC-2502-Y2346Medutest2025-Q199.014.09105.3Buyer-sourced1MARGINAL
AX-2025-019603GHRP-2TFCTFC-2411-A2083Nordanalyt2025-Q199.931.7593.5Buyer-sourced0PASS
AX-2025-019370GHRP-2HYBHYB-2501-R7240Medutest2025-Q199.934.61—Buyer-sourced0PASS
AX-2025-018961TirzepatideASYASY-{CAT}-1489Nordanalyt2025-Q198.856.73—Buyer-sourced0PASS
AX-2025-021023PT-141 (Bremelanotide)WXTWXT-2411-R3766Nordanalyt2025-Q198.725.40103.2Buyer-sourced0PASS
AX-2025-020993CJC-1295 with DACWXTWXT-2409-Y3760Janoshik2025-Q196.995.8198.1Buyer-sourced1FAIL
AX-2025-020683SelankSGNSGN-2409-H8807PeptideMeter2025-Q198.215.84—Buyer-sourced0FAIL
AX-2025-019366TirzepatideHYBHYB-2408-R7015PeptideMeter2025-Q197.985.6394.9Buyer-sourced0PASS
AX-2025-018510SemaglutideWWBWWB-2501-K3141Janoshik2025-Q198.044.40—Buyer-sourced1MARGINAL
AX-2025-020596SermorelinSSASSA-2409-X7161Medutest2025-Q198.464.84100.9Buyer-sourced1FAIL
AX-2025-020187BPC-157ERPERP-2502-P9890Medutest2025-Q199.923.77—Buyer-sourced0PASS
AX-2025-020068P21SWBSWB-2408-T8372Nordanalyt2025-Q199.528.16—Buyer-sourced0PASS
AX-2025-019656AfamelanotideTFCTFC-2502-Y2346Janoshik2025-Q199.415.01105.9Buyer-sourced1MARGINAL
AX-2025-019179Enclomiphene citrateSinoPepSNP-2412-F3914Kestrel2025-Q199.935.1696.8Buyer-sourced1FAIL
AX-2025-019178Enclomiphene citrateSinoPepSNP-2412-F3914Nordanalyt2025-Q199.435.15101.7Buyer-sourced1FAIL
AX-2025-018923CJC-1295 with DACTFSTFS-{CAT}-9795Janoshik2025-Q199.313.0790.8Buyer-sourced2MARGINAL
AX-2025-018922CJC-1295 with DACTFSTFS-{CAT}-9795Janoshik2025-Q199.062.4689.8Buyer-sourced3MARGINAL
AX-2025-018680TB-500QSCQSC-2411-X6249Medutest2025-Q199.175.29—Buyer-sourced0PASS
AX-2025-018442SemaglutideWWBWWB-2501-Y2776Janoshik2025-Q199.633.98100.1Buyer-sourced0PASS
AX-2025-021163SemaglutidePPGPPG-2408-B6709Nordanalyt2025-Q198.575.3991.7Laboratory-retained0PASS
AX-2025-020297BPC-157GGPepsGGPE-2502-S2559PeptideMeter2025-Q198.633.3294.3Buyer-sourced0PASS
AX-2025-020225SemaglutideGGPepsGGPE-2501-W1875PeptideMeter2025-Q198.295.63103.5Laboratory-retained0PASS
AX-2025-019639TB-500TFCTFC-2412-A1938Janoshik2025-Q199.813.21103.3Buyer-sourced0PASS
AX-2025-018662TirzepatideQSCQSC-2410-R5814Medutest2025-Q199.144.96—Buyer-sourced0PASS
AX-2025-018578SemaglutideQYBQYB-2410-V4909Janoshik2025-Q199.734.09101.1Buyer-sourced0PASS
AX-2025-021024PT-141 (Bremelanotide)WXTWXT-2411-R3766Janoshik2025-Q198.425.5293.4Buyer-sourced0FAIL